Gadolinium is a chemical element that is often used in MRI (Magnetic Resonance Imaging), MRA (Magnetic Resonance Angiogram), X-Ray, and other imaging technology as a contrast agent. Contrast agents are dyes that are injected into the body of a patient being imaged in order to enhance the quality of the image. However, serious concerns have been raised about the use of gadolinium, particularly in patients who have pre-existing kidney problems or renal disease. In 2007, the Food and Drug Administration (FDA) issued a Black Box Warning for Gadolinium based contrast agents used in MRIs and MRAs because patients with severe kidney problems who are injected with a Gadolinium based contrast agent are at risk of developing Nephrogenic Systemic Fibrosis (NSF). NSF, which is also referred to as Nephrogenic Fibrosing Dermopathy (NFD), is a potentially deadly disease that causes fibrosis of the eyes, joints, skin and internal organs. If you or a loved one has been diagnosed with NSF/NFD following the injection of a Gadolinium contrast agent in the course of an MRI, MRA, or X-Ray, you may be eligible to recover compensation. Fill out the form on this page to find out if you are eligble to participate in a Gadolinium lawsuit.

• Alabama
  
• Alaska
  
• Arizona
  
• Arkansas
  
• California
  
• Colorado
  
• Connecticut
  
• Delaware
  
• District of Columbia
  
• Florida
  
• Georgia
  

• Hawaii
  
• Idaho
  
• Illinois
  
• Indiana
  
• Iowa
  
• Kansas
  
• Kentucky
  
• Louisiana
  
• Maine
  
• Maryland
  

• Massachusetts
  
• Michigan
  
• Minnesota
  
• Mississippi
  
• Missouri
  
• Montana
  
• Nebraska
  
• Nevada
  
• New Hampshire
  
• New Jersey
  

• New Mexico
  
• New York
  
• North Carolina
  
• North Dakota
  
• Ohio
  
• Oklahoma
  
• Oregon
  
• Pennsylvania
  
• Rhode Island
  
• South Carolina
  

• South Dakota
  
• Tennessee
  
• Texas
  
• Utah
  
• Vermont
  
• Virginia
  
• Washington
  
• West Virginia
  
• Wisconsin
  
• Wyoming